Miller D
Department of Public Health Medicine, United Medical and Dental Schools of Guy's and St. Thomas's, University of London, United Kingdom.
Clin Infect Dis. 1999 Feb;28(2):230-3. doi: 10.1086/515121.
Achievements in the control of acute respiratory infection (ARI) owe much to international collaboration in research, education, and delivery of services. This article highlights some of the current activities of the many international agencies involved and summarizes thoughts on their future roles. Key recent scientific advances include better surveillance, new and improved vaccines, refinement of standard clinical management plans and behavioral change techniques, and demonstration of the effectiveness of their application. Agencies involved include the World Health Organization, the International Union Against Tuberculosis and Lung Disease, national government agencies for overseas aid, many academic departments, and professional lung health associations. However, much remains to be done, especially in collaborative research, in the devising, implementing, and evaluating of health care delivery systems in low-income countries, and in mobilizing political will and resources. These are tasks beyond the capacity of any lone agency. Success will depend on how effectively we collaborate.
急性呼吸道感染(ARI)防控工作取得的成就很大程度上归功于研究、教育及服务提供方面的国际合作。本文重点介绍了众多相关国际机构当前开展的一些活动,并总结了对其未来作用的思考。近期的主要科学进展包括加强监测、研发新的和改良的疫苗、完善标准临床管理方案及行为改变技术,并证明了这些措施应用的有效性。参与的机构包括世界卫生组织、国际防痨和肺部疾病联盟、各国政府的海外援助机构、许多学术部门以及专业肺部健康协会。然而,仍有许多工作要做,特别是在合作研究、设计、实施和评估低收入国家的医疗服务体系,以及调动政治意愿和资源方面。这些任务绝非任何单个机构所能胜任。成功将取决于我们合作的有效性。